Opinion: Biopharma Should Prioritize Research on the Economics of Therapies
Health economics and outcomes research (HEOR) is a critical but sometimes overlooked part of drug development. Decentralized trials now make it easy.
Opinion: Biopharma Should Prioritize Research on the Economics of Therapies Read More »
